CIK 0000748592 · Non-accelerated filer<br>Smaller reporting company
Ernexa Therapeutics Inc.
Sign in to watch- Ticker
- ERNA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 311103425
- Phone
- (617) 798-6700
- Business address
- 1035 CAMBRIDGE STREET, SUITE 18A, CAMBRIDGE, MA, 02141
- Former names
- Eterna Therapeutics Inc., Brooklyn ImmunoTherapeutics, Inc., NTN BUZZTIME INC, NTN COMMUNICATIONS INC
Securities
- ERNA Common Stock Nasdaq
- ERNAW Warrants Nasdaq
- 4 Open-market sale 10% owner sold 327,650 shares at an average $5.55 ($1,816,968)
- 8-K Event Material agreement · Shareholder rights changed · Other events
- 425 Deal Prospectus/Communication re Business Combination
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Regulation FD disclosure
- 8-K Event Delisting notice
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Shares withheld for taxes SVP of Finance gave up 1,178 shares (to pay taxes)
- 4 Shares withheld for taxes CEO gave up 2,453 shares (to pay taxes)
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Agreement ended
- 4 Shares withheld for taxes CEO gave up 170 shares (to pay taxes)
- 4 Shares withheld for taxes SVP of Finance gave up 97 shares (to pay taxes)
- 4 Open-market sale 10% owner sold 12,500 shares at an average $5.99 ($74,910)
- 8-K Event Other events
- 8-K Event Delisting notice
- SC 13D/A Stake Beneficial Ownership Report
- SC 13G/A Stake Amended Statement of Ownership
- SC 13D/A Stake Beneficial Ownership Report
Page 24 of 77 · 1,525 filings